Search - tctmd.com

Displaying 141 - 160 of 177

Sort: Relevancy | Date

News Daily News

In the Early Days of TAVR, No Mortality Penalty for Patients Treated Outside of Trial Centers

October 01, 2015

News Daily News

Registry Study Links CTO PCI to Improved Survival vs Medical Therapy, CABG

September 17, 2015

News Daily News

COURAGE Substudy: PCI Adds No Overall Benefit to OMT Alone in Either Women or Men

L.A. McKeown

August 03, 2015

News Daily News

Bivalirudin Plus GPI Cuts Bleeding, Mortality in Heart Failure Patients Undergoing PCI

June 09, 2015

News Daily News

Transcatheter Tricuspid Valve Repair Appears Feasible in First-in-Human Case

April 03, 2015

News Daily News

Endovascular Treatment Shows Dramatic Benefits for Large Strokes in 3 Trials

Todd Neale

February 11, 2015

News Daily News

PCI No Less Effective in High-BMI Patients Despite Greater Plaque Burden

January 28, 2015

News Daily News

Culprit-Vessel-Only PCI May Be Better for MI Patients with Multivessel Disease, Cardiogenic Shock

September 11, 2014

News Daily News

Similar Overall Long-Term Outcomes, Less Stent Thrombosis with Newer DES in STEMI

Todd Neale

August 22, 2014

News Daily News

Minimizing Selection Bias Eliminates Transfusion’s Apparent Mortality Link in Acute MI Patients

August 20, 2014

News Daily News

Radial-to-Femoral Crossover Results in Minimal Delay, Has Little Impact on STEMI Outcomes

Yael L. Maxwell

August 20, 2014

News Daily News

Initial Kidney Protection of Off-Pump CABG May Not Last

Caitlin E. Cox

June 04, 2014

News Daily News

Bivalirudin Safer Than Heparin Alone in ‘Real-World’ PCI Patients Without STEMI

Yael L. Maxwell

May 01, 2014

News Daily News

First-in-Man Study Demonstrates Safety, Feasibility of Adipose-Derived Cell Therapy for Heart Failure

April 21, 2014

News Daily News

Collateral Flow Impacts Reperfusion, Outcome in Acute Ischemic Stroke

March 13, 2014

News Daily News

EES Reduce Revascularization vs. BMS Regardless of Kidney Disease Severity

January 09, 2014

News Daily News

Distal Protection Adds Early Boost to Thrombectomy in STEMI, but No Lasting Benefit

L.A. McKeown

September 27, 2013

News Daily News

In Older ACS Patients, Half-Dose Prasugrel as Safe as Clopidogrel But No More Effective

July 25, 2013

News Daily News

Una Comparativa de Tratamientos contra EAC Multivaso halla una Preservación LVEF Similar a los 10 Años

L.A. McKeown

July 24, 2013

News Daily News

Comparison of Therapies in Multivessel CAD Finds Similar LVEF Preservation at 10 Years

L.A. McKeown

July 24, 2013

Advertisement

In the Early Days of TAVR, No Mortality Penalty for Patients Treated Outside of Trial Centers

Registry Study Links CTO PCI to Improved Survival vs Medical Therapy, CABG

COURAGE Substudy: PCI Adds No Overall Benefit to OMT Alone in Either Women or Men

Bivalirudin Plus GPI Cuts Bleeding, Mortality in Heart Failure Patients Undergoing PCI

Transcatheter Tricuspid Valve Repair Appears Feasible in First-in-Human Case

Endovascular Treatment Shows Dramatic Benefits for Large Strokes in 3 Trials

PCI No Less Effective in High-BMI Patients Despite Greater Plaque Burden

Culprit-Vessel-Only PCI May Be Better for MI Patients with Multivessel Disease, Cardiogenic Shock

Similar Overall Long-Term Outcomes, Less Stent Thrombosis with Newer DES in STEMI

Minimizing Selection Bias Eliminates Transfusion’s Apparent Mortality Link in Acute MI Patients

Radial-to-Femoral Crossover Results in Minimal Delay, Has Little Impact on STEMI Outcomes

Initial Kidney Protection of Off-Pump CABG May Not Last

Bivalirudin Safer Than Heparin Alone in ‘Real-World’ PCI Patients Without STEMI

First-in-Man Study Demonstrates Safety, Feasibility of Adipose-Derived Cell Therapy for Heart Failure

Collateral Flow Impacts Reperfusion, Outcome in Acute Ischemic Stroke

EES Reduce Revascularization vs. BMS Regardless of Kidney Disease Severity

Distal Protection Adds Early Boost to Thrombectomy in STEMI, but No Lasting Benefit

In Older ACS Patients, Half-Dose Prasugrel as Safe as Clopidogrel But No More Effective

Una Comparativa de Tratamientos contra EAC Multivaso halla una Preservación LVEF Similar a los 10 Años

Comparison of Therapies in Multivessel CAD Finds Similar LVEF Preservation at 10 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content